September 2023
Discovery on Target 2023
Posters
September 2023
Discovery on Target 2023
Discovery and Antifibrotic Activity of an Anti-LTBP-TGFβ1 Inhibitory Antibody
June 2023
Cure SMA 2023 Annual SMA Conference
Effect of Apitegromab on Motor Function and PEDICAT and PROMIS at 36 Months in Patients with Type 2 and Nonambulatory Type 3 Spinal Muscular Atrophy: Combined Presentation of the Phase 2 TOPAZ Study
March 2023
2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Apitegromab in SMA (TOPAZ trial): Covariates of Multiple Efficacy Endpoints From 24 Month Data
March 2023
European Society for Medical Oncology Targeted Anticancer Therapies (ESMO TAT) Congress
Safety and efficacy results of SRK-181 (a latent TGFβ1 inhibitor) from a phase 1 trial (DRAGON trial)
November 2022
American College of Toxicology Annual Meeting 2022